Alzheimer's disease
Skin Cancer Dx Firm Speclipse Raises Nearly $8M to Expand Business
The South Korean company plans to use the funding to develop its laser spectroscopy and artificial intelligence technologies for blood analysis.
Although there is still demand for the company's COVID-19 products, it has also launched tests for cardiovascular disease, Alzheimer's, and more.
Infinity BiologiX to Offer Cytox Alzheimer's Disease Genetic Risk Test in US
Based on Cytox's GenoScore platform, IBX will provide a laboratory-developed test at its CLIA-certified, CAP-accredited lab in Piscataway, New Jersey.
C2N Building Case for Alzheimer's Dx as Aducanumab Approval Promises to Impact Testing Space
Premium
FDA's approval of the Biogen anti-amyloid Alzheimer's drug could drive demand for new tests for the disease, including potentially C2N's blood-based assay.
Alzheon, Czech Institute of Organic Chemistry and Biochemistry Partner on Alzheimer's Test
The partners will develop an assay to measure neurotoxic beta amyloid oligomers in human cerebrospinal fluid.